Product Name

  • Name

    Docusate sodium

  • EINECS 209-406-4
  • CAS No. 577-11-7
  • Article Data12
  • CAS DataBase
  • Density 1.1 g/cm3
  • Solubility 1.5 g/100 mL (25 °C) in water
  • Melting Point 153-157 °C
  • Formula C20H37NaO7S
  • Boiling Point 82.7°C
  • Molecular Weight 444.565
  • Flash Point 91-95 °C
  • Transport Information
  • Appearance odorless colorless to white waxy solid
  • Safety 26-39-37/39-36
  • Risk Codes 22-38-41-36/37/38
  • Molecular Structure Molecular Structure of 577-11-7 (Docusate sodium)
  • Hazard Symbols HarmfulXn,IrritantXi
  • Synonyms AerosolOT-B (6CI);Lutensit A-BOS;M 75;Mackanate DOS 75;Manoxol OT;Marlinat DF 8;Miconate DOS;Modane Soft;Molatoc;Molcer;Molofac;Monawet MO 70;Monawet MO 70E;AOT 100;Acrosol OT100;Adekacol EC 4500;Aerosol OT;Aerosol OT 75PG;Aerosol OT-A;Aerosol OT-S;Airrol CT 1;Astrowet O 75;Bis(2-ethylhexyl) sodiumsulfosuccinate;Carabon DA 72;Celanol DOS 75;Colace;Complemix;Coprol;Correctol Stool Softener Laxative;DOSS;DSS;Di(2-ethylhexyl) sulfosuccinate sodium salt;Dioctyl-Medo Forte;Disponil SUS-IC 875;Docusate sodium;SINONATE 290MH;dioctyl sodium sulfosuccinate;Sodium Dioctyl sulfosuccinate;
  • PSA 118.18000
  • LogP 4.89030

Synthetic route

maleic anhydride
108-31-6

maleic anhydride

2-Ethylhexyl alcohol
104-76-7

2-Ethylhexyl alcohol

sodium docusate
577-11-7

sodium docusate

Conditions
ConditionsYield
Stage #1: maleic anhydride; 2-Ethylhexyl alcohol at 60 - 130℃; under 760.051 Torr; for 3.5h;
Stage #2: With sodium hydrogensulfite; sodium hydroxide In water at 107℃; for 1h; Reagent/catalyst; Temperature;
98.2%
bis(2-ethylhexyl) maleate

bis(2-ethylhexyl) maleate

sodium docusate
577-11-7

sodium docusate

Conditions
ConditionsYield
With sodium metabisulfite In ethanol for 10h; Temperature; Time; Inert atmosphere; Reflux;94%
2-(methoxycarbonylamino)-1H-benzimidazole-1-carboxylic acid

2-(methoxycarbonylamino)-1H-benzimidazole-1-carboxylic acid

A

sodium docusate
577-11-7

sodium docusate

B

sodium ligninsulfonate

sodium ligninsulfonate

cobalt bis(2-ethylhexyl) sulfosuccinate

cobalt bis(2-ethylhexyl) sulfosuccinate

sodium docusate
577-11-7

sodium docusate

Conditions
ConditionsYield
With sodium tetrahydroborate In ethanol; n-heptane
bis(2-ethylhexyl) maleate
142-16-5

bis(2-ethylhexyl) maleate

sodium docusate
577-11-7

sodium docusate

Conditions
ConditionsYield
With sodium disulfite In water at 104℃; for 3.16667h; Inert atmosphere;
choline chloride
67-48-1

choline chloride

sodium docusate
577-11-7

sodium docusate

choline dioctylsulfosuccinate
1214261-62-7

choline dioctylsulfosuccinate

Conditions
ConditionsYield
In water; acetone at 20℃;100%
procainamide hydrochloride
614-39-1

procainamide hydrochloride

sodium docusate
577-11-7

sodium docusate

procainamide docusate
1234189-07-1

procainamide docusate

Conditions
ConditionsYield
In water; acetone at 20℃;100%
sodium docusate
577-11-7

sodium docusate

tramadol hydrochloride

tramadol hydrochloride

tramadolium docusate

tramadolium docusate

Conditions
ConditionsYield
In water; acetone at 20℃;100%
(E)-1-(2-(3,7-dimethylocta-2,6-dienyloxy)-2-oxoethyl)-3-methyI-1H-imidazol-3-ium chloride
1234188-85-2

(E)-1-(2-(3,7-dimethylocta-2,6-dienyloxy)-2-oxoethyl)-3-methyI-1H-imidazol-3-ium chloride

sodium docusate
577-11-7

sodium docusate

(E)-1-(2-(3,7-dimethylocta-2,6-dienyloxy)-2-oxoethyl)-3-methyI-1H-imidazol-3-ium docusate
1234188-87-4

(E)-1-(2-(3,7-dimethylocta-2,6-dienyloxy)-2-oxoethyl)-3-methyI-1H-imidazol-3-ium docusate

Conditions
ConditionsYield
In water; acetone at 20℃;100%
sodium docusate
577-11-7

sodium docusate

rasagiline
136236-51-6

rasagiline

rasagiline docusate
1260684-42-1

rasagiline docusate

Conditions
ConditionsYield
Stage #1: sodium docusate With hydrogenchloride In dichloromethane; water
Stage #2: rasagiline In acetone for 2h; Product distribution / selectivity;
100%
sodium docusate
577-11-7

sodium docusate

phenergan
58-33-3

phenergan

promethazine docusate
1234189-02-6

promethazine docusate

Conditions
ConditionsYield
In water; acetone at 20℃;99%
2-(1H,1H,2H,2H-perfluorooctylthio)-1-methylimidazolium chloride

2-(1H,1H,2H,2H-perfluorooctylthio)-1-methylimidazolium chloride

sodium docusate
577-11-7

sodium docusate

2-(1H,1H,2H,2H-perfluorooctylthio)-1-methylimidazolium docusate

2-(1H,1H,2H,2H-perfluorooctylthio)-1-methylimidazolium docusate

Conditions
ConditionsYield
In acetone at 20℃;99%
acidine
590-46-5

acidine

sodium docusate
577-11-7

sodium docusate

betainium docusate

betainium docusate

Conditions
ConditionsYield
In ethanol at 25℃;99%
ephedrine hydrochloride
50-98-6

ephedrine hydrochloride

sodium docusate
577-11-7

sodium docusate

ephedrinium docusate
1234188-67-0

ephedrinium docusate

Conditions
ConditionsYield
In water; acetone at 20℃;98%
cabozantinib hydrochloride

cabozantinib hydrochloride

sodium docusate
577-11-7

sodium docusate

cabozantinib docusate

cabozantinib docusate

Conditions
ConditionsYield
In water; ethyl acetate at 20℃;98%
sodium docusate
577-11-7

sodium docusate

erlotinib hydrochloride
183319-69-9

erlotinib hydrochloride

erlotinib 1,4-bis(2-ethylhexoxy)-1 ,4-dioxobutane-2-sulfonate

erlotinib 1,4-bis(2-ethylhexoxy)-1 ,4-dioxobutane-2-sulfonate

Conditions
ConditionsYield
In dichloromethane; water at 20℃;98%
vardenafil hydrochloride

vardenafil hydrochloride

sodium docusate
577-11-7

sodium docusate

C23H32N6O4S*C20H38O7S

C23H32N6O4S*C20H38O7S

Conditions
ConditionsYield
In water; ethyl acetate for 4h;98%
sodium docusate
577-11-7

sodium docusate

3,3'-(octane-1,8-diyl)bis(1-methyl-1H-imidazolium) bromide

3,3'-(octane-1,8-diyl)bis(1-methyl-1H-imidazolium) bromide

1,8-bis(3-methylimidazolium-1-yl)octane docusate

1,8-bis(3-methylimidazolium-1-yl)octane docusate

Conditions
ConditionsYield
In water; acetone at 50℃; for 24h;98%
water
7732-18-5

water

sodium docusate
577-11-7

sodium docusate

copper(II) nitrate

copper(II) nitrate

copper(II) bis(2-ethylhexyl)sulfosuccinate tetrahydrate

copper(II) bis(2-ethylhexyl)sulfosuccinate tetrahydrate

Conditions
ConditionsYield
In diethyl ether byproducts: NaNO3; Na compd. completely dissolved in anhyd. ether at room temp.; soln. of Cu(NO3)2 in anhyd. ether added dropwise; stirred for 4 h; NaNO3 removed by supercentrifugation; solvent evapd. from soln.; dried under vac. at 338 K for 24 h; elem. anal.;97%
sodium docusate
577-11-7

sodium docusate

gefitinib
184475-35-2

gefitinib

gefitinib docusate

gefitinib docusate

Conditions
ConditionsYield
With hydrogenchloride In dichloromethane; water at 20℃; for 3.5h;97%
sildenafil hydrochloride
252920-86-8

sildenafil hydrochloride

sodium docusate
577-11-7

sodium docusate

C22H30N6O4S*C20H38O7S

C22H30N6O4S*C20H38O7S

Conditions
ConditionsYield
In water; ethyl acetate for 3h;97%
C53H112N2(2+)*2Br(1-)

C53H112N2(2+)*2Br(1-)

sodium docusate
577-11-7

sodium docusate

C53H112N2(2+)*2C20H37O7S(1-)

C53H112N2(2+)*2C20H37O7S(1-)

Conditions
ConditionsYield
In water; ethyl acetate at 20℃;97%
sodium docusate
577-11-7

sodium docusate

donepezil hydrochloride

donepezil hydrochloride

donepezil docusate

donepezil docusate

Conditions
ConditionsYield
In water at 20℃; for 4h;96.54%
ceritinib hydrochloride

ceritinib hydrochloride

sodium docusate
577-11-7

sodium docusate

ceritinib docusate

ceritinib docusate

Conditions
ConditionsYield
In water; ethyl acetate for 4h;96%
Gefitinib hydrochloride
184475-55-6

Gefitinib hydrochloride

sodium docusate
577-11-7

sodium docusate

gefitinib docusate

gefitinib docusate

Conditions
ConditionsYield
In dichloromethane; water at 20℃;96%
3-methyl-2-(3-methyl-5-phenyl-3H-benzooxazol-2-ylidenemethyl)benzothiazol-3-ium p-toluenesulfonate

3-methyl-2-(3-methyl-5-phenyl-3H-benzooxazol-2-ylidenemethyl)benzothiazol-3-ium p-toluenesulfonate

sodium docusate
577-11-7

sodium docusate

C23H19N2OS(1+)*C20H37O7S(1-)

C23H19N2OS(1+)*C20H37O7S(1-)

Conditions
ConditionsYield
In dichloromethane; water at 20℃; for 12h;96%
N,N-dibenzyl-N,N-tetraethylhexane-1,6-diaminium bromide

N,N-dibenzyl-N,N-tetraethylhexane-1,6-diaminium bromide

sodium docusate
577-11-7

sodium docusate

2C20H37O7S(1-)*C28H46N2(2+)

2C20H37O7S(1-)*C28H46N2(2+)

Conditions
ConditionsYield
In water; ethyl acetate at 20℃;96%
sodium docusate
577-11-7

sodium docusate

bis(2-ethylhexyl) sulfosuccinate
10041-19-7

bis(2-ethylhexyl) sulfosuccinate

Conditions
ConditionsYield
With hydrogenchloride In isopropyl alcohol at 70℃; for 3h;95.4%
With phosphoric acid In ethanol for 2h;
With hydrogenchloride In tetrahydrofuran; methanol at 0℃;
With hydrogenchloride In water at 20℃;
tetrabutylammomium bromide
1643-19-2

tetrabutylammomium bromide

sodium docusate
577-11-7

sodium docusate

tetrabutylammonium docusate

tetrabutylammonium docusate

Conditions
ConditionsYield
In water94%
1-tributyl-(2-hydroxyethyl)phosphonium chloride
54580-84-6

1-tributyl-(2-hydroxyethyl)phosphonium chloride

sodium docusate
577-11-7

sodium docusate

tri-n-butyl(2-hydroxyethyl)phosphonium docusate
1234189-12-8

tri-n-butyl(2-hydroxyethyl)phosphonium docusate

Conditions
ConditionsYield
In water; acetone at 20℃;92%
In water; acetone at 20℃;92%
1,3,3-Trimethyl-2-methyleneindoline
118-12-7

1,3,3-Trimethyl-2-methyleneindoline

ehyl 2-[N-ethoxyformyl methyl-N-(4-formylphenyl)]amino acetate
27919-79-5

ehyl 2-[N-ethoxyformyl methyl-N-(4-formylphenyl)]amino acetate

sodium docusate
577-11-7

sodium docusate

C27H33N2O4(1+)*C20H37O7S(1-)

C27H33N2O4(1+)*C20H37O7S(1-)

Conditions
ConditionsYield
Stage #1: 1,3,3-Trimethyl-2-methyleneindoline; ethyl 2-[N-ethoxyformyl methyl-N-(4-formylphenyl)]aminoacetate With acetic anhydride; acetic acid at 80℃; for 3h;
Stage #2: sodium docusate In ethyl acetate
92%
sodium docusate
577-11-7

sodium docusate

N-dodecylbetainium chloride
55142-08-0

N-dodecylbetainium chloride

C16H34NO2(1+)*C20H37O7S(1-)

C16H34NO2(1+)*C20H37O7S(1-)

Conditions
ConditionsYield
In ethanol at 25℃;92%
thiabendazole hydrochloride
945-65-3

thiabendazole hydrochloride

sodium docusate
577-11-7

sodium docusate

thiabendazolium docusate
1337932-57-6

thiabendazolium docusate

Conditions
ConditionsYield
In water; acetone at 20℃;91%

Docusate sodium Specification

The IUPAC name of Docusate sodium is sodium 1,4-bis(2-ethylhexoxy)-1,4-dioxobutane-2-sulfonate. With the CAS registry number 577-11-7, it is also named as Di-(2-ethylhexyl) sodium sulfosuccinate. The product's categories are Hair Care; Skin Care; Anionic Surfactants; Functional Materials; Sulfonate (Surfactants); Surfactants, and the other registry numbers are 105956-73-8; 106396-28-5; 110162-65-7; 113255-61-1; 130390-93-1; 135843-72-0; 138893-51-3; 141092-35-5; 201816-76-4; 202352-75-8, etc. Besides, it is odorless colorless to white waxy solid, which should be stored in sealed, cool and dry place at 2-8 °C. The chemical is stable, combustible, and incompatible with strong oxidizing agents. In addition, its molecular formula is C20H37NaO7S and molecular weight is 444.56.

Physical properties about Docusate sodium are: (1)ACD/LogP: 5.964; (2)# of Rule of 5 Violations: 1; (3)ACD/LogD (pH 5.5): 2.47; (4)ACD/LogD (pH 7.4): 2.46; (5)ACD/BCF (pH 5.5): 6.43; (6)ACD/BCF (pH 7.4): 6.35; (7)ACD/KOC (pH 5.5): 13.39; (8)ACD/KOC (pH 7.4): 13.23; (9)#H bond acceptors: 7; (10)#H bond donors: 1; (11)#Freely Rotating Bonds: 18;

Preparation of Docusate sodium: this chemical can be prepared by Sodium metabisulfite and Diisooctyl maleate. Frist, you can use Diisooctyl maleate to react with aliphatic alcohol.



Then use the resultant to react with Sodium metabisulfite by heating.

Uses of Docusate sodium: this chemical is an anionic surfactant and a common ingredient in consumer products, especially laxatives of the stool softener type. It also can be used as surfactant in reverse micelle encapsulation studies. Similarly, it is a pesticide used popularly for crops of olives, almonds, wine grapes, corn and oranges. The product is an excellent emulsifier, detergent and penetrant that is used in textile industry.

When you are using this chemical, please be cautious about it as the following: it is irritating to eyes, respiratory system and skin. It is also harmful if swallowed and risk of serious damage to the eyes. In case of contact with eyes, please rinse immediately with plenty of water and seek medical advice. And you should wear suitable protective clothing, gloves and eye/face protection.

You can still convert the following datas into molecular structure:
(1)SMILES: [Na+].[O-]S(=O)(=O)C(C(=O)OCC(CC)CCCC)CC(=O)OCC(CC)CCCC
(2)InChI: InChI=1/C20H38O7S.Na/c1-5-9-11-16(7-3)14-26-19(21)13-18(28(23,24)25)20(22)27-15-17(8-4)12-10-6-2;/h16-18H,5-15H2,1-4H3,(H,23,24,25);/q;+1/p-1;
(3)InChIKey: APSBXTVYXVQYAB-REWHXWOFAT;

The toxicity data is as follows:;

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intravenous 60mg/kg (60mg/kg)   Journal of the American Pharmaceutical Association, Scientific Edition. Vol. 38, Pg. 428, 1949.
mouse LD50 oral 2643mg/kg (2643mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) Drug and Chemical Toxicology. Vol. 1, Pg. 89, 1977/1978.
rat LD50 intraperitoneal 590mg/kg (590mg/kg) VASCULAR: STRICTIRA; CJAMGES OM VESSE;S Bromatologia i Chemia Toksykologiczna. Vol. 7, Pg. 161, 1974.
rat LD50 oral 1900mg/kg (1900mg/kg)   Journal of the Society of Cosmetic Chemists. Vol. 13, Pg. 469, 1962.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View